[Mechanism of Picrorhizae Rhizoma against functional constipation in mice: an exploration based on 16S rDNA and GC-MS].

作者信息

Hu Yu, You Yan-Nan, Zhao Xia, Dong Ying-Mei, Hou Shu-Ting

机构信息

Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029, China Nantong Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine Nantong 226001, China Jiangsu Provincial Key Laboratory of Children's Respiratory Diseases (Traditional Chinese Medicine) Nanjing 210023, China Institute of Pediatrics of Traditional Chinese Medicine, Nanjing University of Chinese Medicine Nanjing 210023, China.

Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029, China Jiangsu Provincial Key Laboratory of Children's Respiratory Diseases (Traditional Chinese Medicine) Nanjing 210023, China Institute of Pediatrics of Traditional Chinese Medicine, Nanjing University of Chinese Medicine Nanjing 210023, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2022 Jul;47(13):3569-3580. doi: 10.19540/j.cnki.cjcmm.20211210.401.

Abstract

The study was designed to determine the influences of Picrorhizae Rhizoma on gut microbiota and metabolites in mice with functional constipation(FC). ICR mice were divided into the blank control group, model group, and the low-, middle-, and high-dose Picrorhizae Rhizoma groups. Mice in the model and low-, middle-, and high-dose Picrorhizae Rhizoma groups were modeled with loperamide hydrochloride. After successful modeling, the ones in the low-, middle-, and high-dose Picrorhizae Rhizoma groups were gavaged with Picrorhizae Rhizoma at the corresponding doses for seven days. The first appearance time of tarry stool, the total fecal volume within 3 h, the fecal moisture content, and the intestinal transit rate were observed in each group. The pathological changes in intestinal mucosa were detected by HE staining. The flora dynamics in colon content were measured by 16 S rDNA sequencing, followed by the examination of fecal metabolomic profiles by gas chromatography-mass spectrometry(GC-MS). The results showed that the first appearance time of tarry stool in the model group was prolonged. The total fecal volume within 3 h, the fecal moisture content, and the intestinal transit rate were significantly reduced. The colon tissue showed inflammatory cell infiltration. Gut microflora and fecal metabolites changed dramatically. Picrorhizae Rhizoma alleviated the constipation symptoms, repaired intestinal mucosa, and partially restored the gut microbiota and metabolite compositions in mice with constipation. As demonstrated by intestinal microbiota sequencing, Picrorhizae Rhizoma remarkably reduced the Firmicutes/Bacteroidetes ratio and the relative abundance of Lactobacillus, but increased the relative abundance of Muribaculaceae, Enterorhabdus, and Eggerthellaceae. According to the linear discriminant analysis effect size(LefSe), the dominant bacterial species in the Picrorhizae Rhizoma groups were Muribaculaceae, Dubosiella, and Akkermansia. A total of 43 differential metabolites were detected in the feces of mice, involving the D-glutamine and D-glutamate metabolism, glutathione metabolism, arginine biosynthesis, alanine, aspartate and glutamate metabolism, purine metabolism, and pyrimidine metabolism. All these have demonstrated that Picrorhizae Rhizoma enhanced gastrointestinal motility, protectd gastrointestinal mucosa, and alleviated constipation symptoms possibly by regulating the intestinal microbial communities and metabolites and affecting the related metabolic pathways.

摘要

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索